{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:55:28Z","timestamp":1770832528720,"version":"3.50.1"},"reference-count":30,"publisher":"Maad Rayan Publishing Company","issue":"2","content-domain":{"domain":["apb.tbzmed.ac.ir"],"crossmark-restriction":false},"short-container-title":["Adv Pharm Bull"],"abstract":"<jats:p>Purpose: Direct delivery of aminoglycosides to the lungs was under extensive evaluations during the last decades. Because of large particle size, low density and porous structure, large porous particles (LPPs) are versatile carriers for this purpose. In this study, poly (lactic-co-glycolic acid) (PLGA) LPPs encapsulating gentamicin sulfate were prepared and in vitro characteristics of their freeze-dried powder as a dry powder inhaler (DPI) were evaluated.  Methods: To prepare PLGA LPPs, a double emulsification-solvent evaporation method was optimized and gentamicin sulfate was post-loaded in the LPPs. In vitro characteristics including morphological features, thermal behavior, aerodynamic profile and cumulative drug release were evaluated by the scanning electron microscope (SEM), differential scanning calorimetry (DSC), next-generation cascade impactor (NGI) and Franz diffusion cell respectively.  Results: The obtained results revealed that the preparation method was capable to produce spherical large homogenous highly porous particles. 94% of gentamicin sulfate released from LPPs up to 30 minutes. Mass median aerodynamic diameter (MMAD) and fine particle fraction (FPF) were 4.9 \u00b5m and 39% respectively.  Conclusion: In this study, dry powder formulation composed of PLGA LPPs encapsulating gentamicin sulfate showed a promising in vitro behavior as a pulmonary delivery carrier. Improvements on the aerodynamic behavior and in vivo evaluations recommended for further developments.<\/jats:p>","DOI":"10.15171\/apb.2019.029","type":"journal-article","created":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T13:41:32Z","timestamp":1560692492000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.15171\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Preparation and Characterization of a Dry Powder Inhaler Composed of PLGA Large Porous Particles Encapsulating Gentamicin Sulfate"],"prefix":"10.34172","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-0663","authenticated-orcid":true,"given":"Farideh","family":"Shiehzadeh","sequence":"first","affiliation":[{"name":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8286-0973","authenticated-orcid":true,"given":"Mohsen","family":"Tafaghodi","sequence":"additional","affiliation":[{"name":"Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Laal-Dehghani","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faezeh","family":"Mashhoori","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-1493","authenticated-orcid":true,"given":"Bibi Sedigheh","family":"Fazly Bazzaz","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran."},{"name":"Department of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2441-0421","authenticated-orcid":true,"given":"Mohsen","family":"Imenshahidi","sequence":"additional","affiliation":[{"name":"Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20123","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201311-395FR"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027029"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.10.021"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2012.01.026"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2018.1502267"},{"key":"R6","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards DA","year":"1997","journal-title":"Science"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.12.044"},{"key":"R8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3109\/02652048.2014.944949","article-title":"Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization","volume":"32","author":"Alipour S","year":"2015","journal-title":"J Microencapsul"},{"key":"R9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jddst.2018.01.002","article-title":"Fabrication and in vitro evaluation of magnetic PLGA nanoparticles as a potential Methotrexate delivery system for breast cancer","volume":"44","author":"Vakilinezhad MA","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1334-y"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2014.956111"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2006.05.005"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2006.09.045"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.10.005"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.09.006"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9825-2"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2010.07.050"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2017.1310223"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01164-06"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2004.03.010"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2005.07.031"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2010.10.045"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1081\/pdt-100100543"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2008.08.039"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.03.013"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9313-3"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-009-9290-6"},{"key":"R28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1570-0232(01)00636-5","article-title":"Determination of gentamicin in urine samples after inhalation by reversed-phase high-performance liquid chromatography using pre-column derivatisation with o-phthalaldehyde","volume":"769","author":"Al-Amoud AI","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R29","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0731-7085(99)00192-2","article-title":"A validated quantitative colorimetric assay for gentamicin","volume":"21","author":"Frutos P","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2452-z"}],"container-title":["Advanced Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/apb.tbzmed.ac.ir\/PDF\/apb-25397","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/apb.tbzmed.ac.ir\/PDF\/apb-25397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T16:11:21Z","timestamp":1581696681000},"score":1,"resource":{"primary":{"URL":"https:\/\/apb.tbzmed.ac.ir\/Abstract\/apb-25397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,6]]}},"URL":"https:\/\/doi.org\/10.15171\/apb.2019.029","relation":{},"ISSN":["2228-5881","2251-7308"],"issn-type":[{"value":"2228-5881","type":"print"},{"value":"2251-7308","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"Tabriz University of Medical Sciences","name":"journal_owner","label":"Journal Owner"},{"value":"Tabriz University of Medical Sciences","name":"journal_publisher","label":"Journal Publisher"}]}}